Tinidazole: Effective Treatment for Protozoal and Bacterial Infections
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.73 | $43.86 (0%) | 🛒 Add to cart |
| 90 | $0.70 | $65.79 $62.78 (5%) | 🛒 Add to cart |
| 120 | $0.67 | $87.72 $80.84 (8%) | 🛒 Add to cart |
| 180 | $0.65 | $131.58 $117.82 (10%) | 🛒 Add to cart |
| 270 | $0.65 | $197.37 $174.58 (12%) | 🛒 Add to cart |
| 360 | $0.64
Best per pill | $263.16 $229.62 (13%) | 🛒 Add to cart |
Synonyms
| |||
Tinidazole is a second-generation nitroimidazole antimicrobial agent prescribed for the treatment of a variety of protozoal and anaerobic bacterial infections. It demonstrates high efficacy, a favorable pharmacokinetic profile, and a generally well-tolerated safety spectrum in appropriate patient populations. This medication is particularly valued for its longer half-life compared to other drugs in its class, allowing for less frequent dosing and potentially improved patient adherence.
Features
- Belongs to the nitroimidazole class of antimicrobials
- Available in 250mg, 500mg, and 1000mg oral tablets
- Exhibits bactericidal and antiprotozoal activity through disruption of DNA synthesis
- Long elimination half-life of approximately 12-14 hours
- Demonstrated activity against Giardia lamblia, Trichomonas vaginalis, Entamoeba histolytica, and anaerobic bacteria
- FDA-approved for specific indications with established clinical guidelines
Benefits
- Provides single-dose or short-course treatment regimens for several infections, reducing treatment duration
- High cure rates in trichomoniasis, giardiasis, and amebiasis with minimal resistance development
- Effective against antibiotic-resistant anaerobic bacterial strains in intra-abdominal infections
- Convenient dosing schedule improves compliance compared to multiple daily dose alternatives
- Well-absorbed orally with excellent tissue penetration, including central nervous system penetration
- Cost-effective therapeutic option for both outpatient and inpatient management
Common use
Tinidazole is primarily indicated for the treatment of trichomoniasis caused by Trichomonas vaginalis in both male and female patients. It is equally effective for intestinal amebiasis (amebic dysentery) and extraintestinal amebiasis (including amebic liver abscess) caused by Entamoeba histolytica. Additionally, it is prescribed for giardiasis caused by Giardia duodenalis (G. lamblia). For anaerobic bacterial infections, tinidazole is used in the treatment of bacterial vaginosis and as part of combination therapy for intra-abdominal infections involving susceptible anaerobic organisms. Off-label uses may include treatment of Clostridium difficile infection, though metronidazole remains first-line for this indication in most guidelines.
Dosage and direction
Dosage varies according to indication, patient weight (in pediatric cases), and renal/hepatic function. For trichomoniasis: single 2g oral dose in adults, or alternatively 1g once daily for 3 days. For giardiasis: single 2g dose in adults, or 50mg/kg (up to 2g) in children older than 3 years. For intestinal amebiasis: 2g daily for 3 days in adults; 50mg/kg/day (up to 2g) for 3 days in children. For amebic liver abscess: 2g daily for 3-5 days in adults; 50mg/kg/day (up to 2g) for 3-5 days in children. For bacterial vaginosis: 2g daily for 2 days, or 1g daily for 5 days. Tablets should be taken with food to minimize gastrointestinal upset. Complete the full prescribed course even if symptoms improve earlier.
Precautions
Tinidazole may cause dizziness or lightheadedness; patients should avoid driving or operating machinery until response is determined. Alcohol consumption must be avoided during treatment and for at least 3 days after completion due to the potential for disulfiram-like reaction (flushing, nausea, vomiting, tachycardia). Use with caution in patients with central nervous system diseases, blood dyscrasias, or hepatic impairment. May cause leukopenia (neutropenia); monitor blood counts if prolonged therapy is necessary. Not recommended during first trimester of pregnancy; use during second and third trimesters only if clearly needed. Excreted in breast milk; interrupt breastfeeding during treatment and for 3 days after last dose.
Contraindications
Hypersensitivity to tinidazole, other nitroimidazole derivatives, or any component of the formulation. Administration during first trimester of pregnancy. Concurrent use with alcohol or alcohol-containing medications. Previous history of tinidazole-associated blood dyscrasias. Use in patients with organic neurological disorders. Concomitant administration with disulfiram (must separate by至少 2 weeks). Not approved for children under 3 years of age.
Possible side effect
Common adverse reactions include metallic taste (most frequent), nausea, vomiting, anorexia, epigastric discomfort, and diarrhea. Neurological effects may include dizziness, headache, and peripheral neuropathy with prolonged use. Less frequently, patients may experience transient leukopenia, allergic reactions (rash, pruritus), darkening of urine, and fatigue. Serious but rare side effects include seizures, encephalopathy, and Stevens-Johnson syndrome. Discontinue immediately if signs of neuropathy occur. Most side effects are dose-related and reversible upon discontinuation.
Drug interaction
Tinidazole potentiates warfarin effect (monitor INR closely). May increase serum levels of lithium, phenytoin, and cyclosporine (monitor levels). Cholestyramine may decrease tinidazole absorption. Concomitant use with CYP3A4 inducers (rifampin, phenytoin) may decrease tinidazole efficacy. Avoid combination with disulfiram due to increased risk of psychotic reactions. Cimetidine may increase tinidazole levels. May prolong PT/INR when used with anticoagulants. Potential interaction with oral typhoid vaccine; separate administration by至少 3 days.
Missed dose
If a dose is missed, take it as soon as remembered unless it is接近 time for the next dose. Do not double the dose to make up for the missed one. Maintain the regular dosing schedule. For single-dose regimens, contact healthcare provider for guidance if dose is missed completely.
Overdose
Symptoms may include nausea, vomiting, dizziness, and ataxia. Severe overdose could lead to seizures or peripheral neuropathy. There is no specific antidote. Management is supportive and symptomatic. Gastric lavage may be considered if presented early. Hemodialysis may enhance elimination due to moderate protein binding. Monitor CBC and neurological status in symptomatic patients.
Storage
Store at controlled room temperature (20-25°C or 68-77°F). Protect from light and moisture. Keep in original container with tight closure. Do not store in bathroom or damp places. Keep out of reach of children and pets. Do not use after expiration date printed on packaging.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Tinidazole is a prescription medication that should be used only under supervision of a qualified healthcare professional. Dosage and treatment duration must be determined by a physician based on individual patient factors. Never self-medicate or share prescription medications. Report any adverse effects to your healthcare provider immediately.
Reviews
Clinical studies demonstrate tinidazole’s efficacy rates of 92-100% for trichomoniasis, 80-100% for giardiasis, and 90-96% for intestinal amebiasis. Systematic reviews confirm non-inferiority to metronidazole with potentially better tolerability profile. Patients report satisfaction with convenient dosing schedule, though metallic taste remains a common complaint. Larger cohort studies show favorable safety profile with appropriate patient selection and monitoring.